Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Roda

Showing results (21-30 of 69) with videos related to

Pageof 7
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 27, 2015
Increased Risk of Oral Cancer in Patients With Inflammatory Bowel DiseasesKonstantinos H Katsanos, Giulia Roda, Russell B McBride, et al.
Frontiers in Immunology|June 3, 2021
The IL23-IL17 Immune Axis in the Treatment of Ulcerative Colitis: Successes, Defeats, and Ongoing ChallengesDaniele Noviello, Riccardo Mager, Giulia Roda, et al.
Annals of Gastroenterology|May 4, 2018
Role of bile acids in inflammatory bowel diseaseElisa Tiratterra, Placido Franco, Emanuele Porru, et al.
World Journal of Gastroenterology|March 22, 2007
A new oral formulation for the release of sodium butyrate in the ileo-cecal region and colonAldo Roda, Patrizia Simoni, Maria Magliulo, et al.
United European Gastroenterology Journal|November 30, 2021
Diversion proctocolitis and the problem of the forgotten rectum in inflammatory bowel diseases: A systematic reviewArianna Dal Buono, Michele Carvello, David B Sachar, et al.
Journal of Proteomics|January 27, 2009
Differential proteomic analysis of HT29 Cl.16E and intestinal epithelial cells by LC ESI/QTOF mass spectrometryPaolo Nanni, Laura Mezzanotte, Giulia Roda, et al.
Expert Review of Gastroenterology & Hepatology|August 9, 2020
Treat to target or 'treat to clear' in inflammatory bowel diseases: one step further?Arianna Dal Buono, Giulia Roda, Marjorie Argollo, et al.
Current Drug Targets|July 29, 2020
'Treat to Target' in Mild to Moderate Ulcerative Colitis: Evidence to Support this StrategyArianna Dal Buono, Giulia Roda, Marjorie Argollo, et al.
Expert Opinion on Biological Therapy|February 26, 2020
Modulation of sphingosine-1-phosphate in ulcerative colitisMarjorie Argollo, Federica Furfaro, Daniela Gilardi, et al.
Nutrients|July 9, 2022
Ileal Pouch-Anal Anastomosis and Pouchitis: The Role of the Microbiota in the Pathogenesis and TherapyRoberto Gabbiadini, Arianna Dal Buono, Carmen Correale, et al.
Pageof 7

Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 27, 2015
Increased Risk of Oral Cancer in Patients With Inflammatory Bowel DiseasesKonstantinos H Katsanos, Giulia Roda, Russell B McBride, et al.
Frontiers in Immunology|June 3, 2021
The IL23-IL17 Immune Axis in the Treatment of Ulcerative Colitis: Successes, Defeats, and Ongoing ChallengesDaniele Noviello, Riccardo Mager, Giulia Roda, et al.
Annals of Gastroenterology|May 4, 2018
Role of bile acids in inflammatory bowel diseaseElisa Tiratterra, Placido Franco, Emanuele Porru, et al.
World Journal of Gastroenterology|March 22, 2007
A new oral formulation for the release of sodium butyrate in the ileo-cecal region and colonAldo Roda, Patrizia Simoni, Maria Magliulo, et al.
United European Gastroenterology Journal|November 30, 2021
Diversion proctocolitis and the problem of the forgotten rectum in inflammatory bowel diseases: A systematic reviewArianna Dal Buono, Michele Carvello, David B Sachar, et al.
Journal of Proteomics|January 27, 2009
Differential proteomic analysis of HT29 Cl.16E and intestinal epithelial cells by LC ESI/QTOF mass spectrometryPaolo Nanni, Laura Mezzanotte, Giulia Roda, et al.
Expert Review of Gastroenterology & Hepatology|August 9, 2020
Treat to target or 'treat to clear' in inflammatory bowel diseases: one step further?Arianna Dal Buono, Giulia Roda, Marjorie Argollo, et al.
Current Drug Targets|July 29, 2020
'Treat to Target' in Mild to Moderate Ulcerative Colitis: Evidence to Support this StrategyArianna Dal Buono, Giulia Roda, Marjorie Argollo, et al.
Expert Opinion on Biological Therapy|February 26, 2020
Modulation of sphingosine-1-phosphate in ulcerative colitisMarjorie Argollo, Federica Furfaro, Daniela Gilardi, et al.
Nutrients|July 9, 2022
Ileal Pouch-Anal Anastomosis and Pouchitis: The Role of the Microbiota in the Pathogenesis and TherapyRoberto Gabbiadini, Arianna Dal Buono, Carmen Correale, et al.
Pageof 7